Multiple MyelomaTransplantation, AutologousHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell MobilizationMelphalanTransplantation ConditioningAntineoplastic Combined Chemotherapy ProtocolsBone MarrowBone Marrow TransplantationStem CellsCombined Modality TherapyHematopoietic Stem CellsLeukapheresisGranulocyte Colony-Stimulating FactorTreatment OutcomeBone Marrow CellsCyclophosphamideGraft vs Host DiseaseHematologic NeoplasmsRemission InductionAntigens, CD34EtoposideBone DiseasesBlood Component RemovalSalvage TherapyLymphoma, Non-HodgkinDisease-Free SurvivalMyeloablative AgonistsRecurrenceBone Marrow PurgingHodgkin DiseaseGraft SurvivalBusulfanCytarabineThiotepaSurvival RateCarmustineWhole-Body IrradiationVincristineAntineoplastic Agents, AlkylatingSurvival AnalysisBoronic AcidsRetrospective StudiesPyrazinesAmyloidosisOsteolysisDexamethasoneDoxorubicinCord Blood Stem Cell TransplantationTissue DonorsTransplantation ChimeraThalidomideIfosfamideTime FactorsPrognosisHematopoiesisFollow-Up StudiesAntineoplastic AgentsLymphomaLeukemia, Myeloid, AcuteLymphoma, Mantle-CellBone and BonesMesenchymal Stem Cell TransplantationPrednisoneEmbryonic Stem CellsBlood CellsNeoplasm, ResidualAntibodies, Monoclonal, Murine-DerivedLeukemiaHistocompatibilityBlood Cell CountHistocompatibility TestingCell DifferentiationPodophyllotoxinBone Marrow DiseasesAdult Stem CellsMyelodysplastic SyndromesImmunosuppressive AgentsLymphoma, FollicularOsteoclastsPlasma CellsFlow CytometryLymphoma, T-Cell, PeripheralAutograftsCells, CulturedVidarabineFeasibility StudiesCarboplatinProspective StudiesNeoplasmsLiver TransplantationAntibodies, MonoclonalInduction ChemotherapyBone NeoplasmsCell SeparationLeukemia, Plasma CellMitoxantrone